HIGHLIGHTS
- who: Bianca Reis Santos from the Instituto Venezolano University of Cambridge, United Kingdom have published the article: Kisspeptin treatment improves fetal-placental development and blocks placental oxidative damage caused by maternal hypothyroidism in an experimental rat model, in the Journal: (JOURNAL)
- what: The authors demonstrate that daily kisspeptin treatment improves development of the fetus and placenta in hypothyroid rats, increases the expression of growth factors and antioxidant enzymes by the placenta, and positively modulates oxidative stress, reticular stress and immune mediators, thus characterizing the therapeutic potential of kisspeptin in a gestational disease for the first . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.